To compare the effects of heparin thrombolytic agents in pulmonary thromboembolic disease, we randomly assigned 40 patients with pulmonary emboli but without other clinical cardiopulmonary disease either to heparin followed by oral anticoagulants (21 patients) or to urokinse or streptokinase followed by heparin and then by oral anticoagulants (19 patients). The effects on pulmonary-capillary blood volume and diffusing capacity were compared at two weeks and at one year. The pulmonary-capillary blood volume (in milliliters per square meter of body-surface area) was abnormally low (30 +/- 2.4) [+/- S.E.]; normal, 47 +/- 1.5) in the heparin-treated group at two weeks and remained unchanged at one year. In contrast, it was normal (45 +/- 2.5) in the group receiving thrombolytic agents, both at two weeks and at one year (P < 0.001). The pulmonary diffusing capacity was reduced to 69% of the predicted value in the heparin group at two weeks and 72% at one year, whereas it was 85% of the predicted value in the thrombolytic group at two weeks and 93% at one year (P < 0.001). These results indicate that thrombolytic agents allow more complete resolution of thromboemboli than do heparin and anticoagulants and that they improve capillary perfusion and diffusion.
This article has been cited by other articles:
Buller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., Raskob, G. E.
(2004). Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 401S-428S
[Abstract][Full Text]
Wan, S., Quinlan, D. J., Agnelli, G., Eikelboom, J. W.
(2004). Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism: A Meta-Analysis of the Randomized Controlled Trials. Circulation
110: 744-749
[Abstract][Full Text]
Zagorski, J., Debelak, J., Gellar, M., Watts, J. A., Kline, J. A.
(2003). Chemokines Accumulate in the Lungs of Rats with Severe Pulmonary Embolism Induced by Polystyrene Microspheres. J. Immunol.
171: 5529-5536
[Abstract][Full Text]
Meneveau, N., Ming, L. P., Seronde, M. F., Mersin, N., Schiele, F., Caulfield, F., Bernard, Y., Bassand, J.-P.
(2003). In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy. Eur Heart J
24: 1447-1454
[Abstract][Full Text]
Baker, W. F. Jr
(2002). Thrombolytic Therapy. CLIN APPL THROMB HEMOST
8: 291-314
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., Weg, J. G.
(2001). Antithrombotic Therapy for Venous Thromboembolic Disease. Chest
119
: 176S-193S
[Full Text]
Sharma, G., Folland, E. D, McIntyre, K. M, Sasahara, A. A
(2000). Long-term benefit of thrombolytic therapy in patients with pulmonary embolism. Vasc Med
5: 91-95
[Abstract]
Goldhaber, S. Z
(2000). A contemporary approach to thrombolytic therapy for pulmonary embolism. Vasc Med
5: 115-123
[Abstract]
Thomas, M.D., Chauhan, A., More, R.S.
(2000). Pulmonary embolism--an update on thrombolytic therapy. QJM
93: 261-267
[Full Text]
Arcasoy, S. M., Kreit, J. W.
(1999). Thrombolytic Therapy of Pulmonary Embolism: A Comprehensive Review of Current Evidence. Chest
115: 1695-1707
[Abstract][Full Text]
Hull, R. D., Pineo, G. F.
(1997). Overview of Treatment of Venous Thromboembolism Based on Levels of Evidence. CLIN APPL THROMB HEMOST
3: S68-S71
Hastings, G. E., Seery, D. S., Vine, D. L.
(1993). Recent Developments in the Diagnosis, Treatment, and Prevention of Pulmonary Embolism. Arch Fam Med
2: 655-669
[Abstract]
Sidorov, J.
(1989). Streptokinase vs Heparin for Deep Venous Thrombosis: Can Lytic Therapy Be Justified?. Arch Intern Med
149: 1841-1845
[Abstract]
Harris, E. J. JR, Porter, J. M.
(1989). Thrombolytic Therapy and Modern Vascular Surgery: An Overview. PERSPECT VASC SURG ENDOVASC THER
2: 40-63
Landercasper, J., Gall, W., Fischer, M., Boyd, W. C., Dahlberg, P. J., Kisken, W. A., Boland, T.
(1987). Thrombolytic Therapy of AxillarySubclavian Venous Thrombosis. Arch Surg
122: 1072-1075
[Abstract]
Grau, E., Fontcuberta, J., Pages, M.A., Martinez, R., Felez, J., Net, A., Rutllant, M. Ll.
(1986). Massive Pulmonary Embolism: Short-Term Effects of Thrombolytic Treatment. ANGIOLOGY
37: 832-839
[Abstract]
Sasahara, A. A., Sharma, G. V. R. K., Barsamian, E. M., Schoolman, M., Cella, G.
(1983). Pulmonary Thromboembolism: Diagnosis and Treatment. JAMA
249: 2945-2950
[Abstract]
Demeter, S. L., Fuenning, C.
(1983). Intra-Pulmonary Artery Streptokinase. ANGIOLOGY
34: 70-77
[Abstract]
Long, D. M.
(1982). Thrombolytic Therapy in Severe Arterial Insufficiency With Absent Distal Pulses. VASC ENDOVASCULAR SURG
16: 219-238
[Abstract]
Sasahara, A. A., Sharma, G.V.R.K., Parisi, A. F., Barsamian, E. M., McIntyre, K. M., Tow, D. E., Cella, G.
(1982). Pulmonary Embolism, Pulmonary Microcirculation, and Thrombolytic Therapy. ANGIOLOGY
33: 368-374
Sasahara, A. A., Sharma, G. V. R. K., Tow, D. E., McIntyre, K. M., Parisi, A. F., Cella, G.
(1982). Clinical Use of Thrombolytic Agents in Venous Thromboembolism. Arch Intern Med
142: 684-688
[Abstract]
Sherry, S.
(1982). Clinical Management of the Thrombosed Vessel: An Overview. ANGIOLOGY
33: 6-10
Previous
